TickerFacts.

Medpace Holdings, Inc. (MEDP): Shareholders' Equity

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2018-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$459.07M
As of 2025-12-31
$433.86M
As of 2026-06-30
+5.9%
3-year compound annual growth
-10.6%
5-year compound annual growth
$952.93M2014-12-31: $401.97M2015-12-31: $413.47M2016-12-31: $610.71M2017-12-31: $503.53M2018-12-31: $598.86M2019-12-31: $726.28M2020-12-31: $805.78M2021-12-31: $952.93M2022-12-31: $386.39M2023-12-31: $558.95M2024-12-31: $825.54M2025-12-31: $459.07M$459.07M
2014-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$459.07M-44.4%2026-02-10, Balance as of period end
2024-12-31$825.54M+47.7%2026-02-10, Balance as of period end
2023-12-31$558.95M+44.7%2026-02-10, Balance as of period end
2022-12-31$386.39M-59.5%2025-02-11, Balance as of period end
2021-12-31$952.93M+18.3%2024-02-13, Balance as of period end
2020-12-31$805.78M+10.9%2023-02-14, Balance as of period end
2019-12-31$726.28M+21.3%2022-02-15, Balance as of period end
2018-12-31$598.86Mn/c2021-02-16, Balance as of period end
2017-12-31$503.53M-17.6%2020-02-25, Balance as of period end
2016-12-31$610.71M+47.7%2019-02-26, Balance as of period end
2015-12-31$413.47M+2.9%2018-02-27, Balance as of period end
2014-12-31$401.97Mn/a2017-02-28, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Medpace Holdings, Inc. (MEDP)2025-12-31$459.07M-44.4%
Charles River Laboratories International, Inc. (CRL)2025-12-27$3.17B-8.6%
Incyte Corp (INCY)2025-12-31$5.17B+49.9%
Icon PLC (ICLR)2025-12-31$9.19B-2.6%
Iqvia Holdings Inc. (IQV)2025-12-31$6.63B+9.3%
NRC Health (NRC)2025-12-31$13.99M-55.3%
MaxCyte, Inc. (MXCT)2025-12-31$171.49M-16.9%
OmniAb, Inc. (OABI)2025-12-31$267.03M-7.2%
Foxo Technologies Inc. (FOXO)2025-12-31$11.14M+109.3%

Compare MEDP, CRL, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗